Sangamo Therapeutics Inc (SGMO) — Long-term Investment Intensity
Sangamo Therapeutics Inc (SGMO) has a Long-term Investment Intensity of 12.0% as of June 2023. Long-term investments of $39.04 Million represent 12.0% of total assets of $325.07 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check SGMO asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Sangamo Therapeutics Inc Long-term Investment Intensity (2013–2022)
This chart shows how Sangamo Therapeutics Inc's Long-term Investment Intensity has evolved across 7 annual periods from 2013 to 2022. As of June 2023, the intensity stands at 12.0%, reflecting long-term investments of $39.04 Million against total assets of $325.07 Million USD. For the complete balance sheet picture, see how large is Sangamo Therapeutics Inc's balance sheet.
Annual Long-term Investment Intensity for Sangamo Therapeutics Inc (2013–2022)
The table below presents the year-by-year Long-term Investment Intensity for Sangamo Therapeutics Inc from 2013 to 2022, covering 7 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read SGMO total debt and obligations for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2022 | 5.3% | $29.84 Million | $562.51 Million | ▼ -6.9 pp |
| 2021 | 12.2% | $88.17 Million | $721.92 Million | ▲ +6.8 pp |
| 2020 | 5.4% | $50.53 Million | $938.55 Million | ▲ +2.0 pp |
| 2019 | 3.4% | $21.83 Million | $637.52 Million | ▲ +3.1 pp |
| 2017 | 0.4% | $1.01 Million | $286.74 Million | ▼ -19.1 pp |
| 2014 | 19.4% | $47.26 Million | $243.21 Million | ▼ -8.0 pp |
| 2013 | 27.5% | $38.66 Million | $140.84 Million | — |